ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The S100 calcium-binding protein A11 promotes hepatic steatosis through RAGE-mediated AKT-mTOR signaling

Teng, Fei; Jiang, Jingjing; Zhang, Jinhua; Yuan, Youwen; Li, Kangli; Zhou, Bing; Zhou, Xuan; Liu, Wenhui; Zhang, Peizhen; Liu, Deying; Zheng, Minghua; Lu, Yan*; Zhang, Huijie*复旦大学; 南方医科大学; 厦门大学; 1; y
Metabolism: Clinical and Experimental2021-4DOI: 10.1016/j.metabol.2021.154725
14被引8阅读
引用收藏
分享

摘要

Rationale: Nonalcoholic fatty liver disease (NAFLD), the most common cause of chronic liver disease, has become an increasingly severe public health problem. However, the underlying mechanism for the occurrence and development of NAFLD remains largely unknown. S100 calcium-binding protein A11 (S100A11) is a multifunctional protein previously reported to be a poor prognostic indicator of hepatocellular carcinoma, while the role of S100A11 affects NAFLD is still not clear. @@@ Methods: Immunohistochemical staining was performed using human NAFLD and control biopsy specimens. Serum level of S100A11 were analyzed by Elisa assays. The S100A11 over-expressed/ knocked-down model was established in vitro or in vivo. The expression levels of genes related to lipid metabolism in liver tissue were performed by quantitative PCR and western blotting. Hepatic lipid accumulation was determined by biochemical measurements and histochemistry. @@@ Results: We showed that the concentration of serum S100A11 was significantly elevated in NAFLD patients, and expression of S100A11 was remarkedly increased in the livers of NAFLD patients and mouse models. Overexpression of S100A11 in vivo markedly increased liver steatosis, body weight, and serum aspartate aminotransaminase (AST) levels. Mechanistically, our results demonstrated that S100A11 acted as a positive regulator of AKT/mTOR signaling to induce lipid synthesis and aggravate lipid deposition. @@@ Conclusions: These results provide evidence for a novel role of S100A11 that contributes to hepatic steatosis, suggesting that targeting S100A11 may be an alternative approach for the treatment of NAFLD.

学科与关键词

关键词
ObesityNAFLDLipid metabolismAKTmTOR
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Metabolism: Clinical and Experimental
发表日期
2021-04
卷期
第 117 卷
页码
154725
DOI
10.1016/j.metabol.2021.154725
语言
ENGLISH
期刊收录
NSL
期刊等级
1区
成果收录
SCIE
资助标注
National Key Research and Development Project [2018YFA0800404]; Natural Science Foundation; Key-Area Research and Development Program of Guangdong Province [2018B030311031, 2019B020227004]; Young Foundation of Fujian Provincial Education Department [JAT170711]; National Natural Science Foundation of China [81970736, 82070588]; Distinguished Young Scholars Training Program of Nanfang Hospital

作者

  • T

    Teng, Fei (第一作者)

    southern med univ

  • J

    Jiang, Jingjing

    fudan univ

查看全部 13 位作者收起作者
  • Z

    Zhang, Jinhua

    xiamen med coll

  • Y

    Yuan, Youwen

    southern med univ

  • L

    Li, Kangli

    southern med univ

  • Z

    Zhou, Bing

    fudan univ

  • Z

    Zhou, Xuan

    1 · xiamen univ

  • L

    Liu, Wenhui

    southern med univ

  • Z

    Zhang, Peizhen

    southern med univ

  • L

    Liu, Deying

    southern med univ

  • Z

    Zheng, Minghua

    1 · wenzhou med univ

  • L

    Lu, Yan (通讯)

    fudan univ

  • Z

    Zhang, Huijie (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417